TNIP1 Polymorphisms with the Risk of Hepatocellular Carcinoma Based on Chronic Hepatitis B Infection in Chinese Han Population

被引:4
作者
Cheng, Yujing [1 ]
Jiang, Xiaochun [2 ]
Jin, Jieqiong [3 ]
Luo, Xiongjian [3 ]
Chen, Wanlu [1 ]
Li, Qi [1 ]
Zhang, Chan [1 ]
机构
[1] Kunming Univ Sci & Technol, Affiliated Hosp, Dept Blood Transfus, Peoples Hosp Yunnan Prov 1, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China
[2] Third Peoples Hosp Yunnan Prov, Dept Blood Transfus, Kunming 650000, Yunnan, Peoples R China
[3] Chinese Acad Sci, Kunming Inst Zool, Kunming 650000, Yunnan, Peoples R China
关键词
Hepatocellular carcinoma (HCC); hepatitis B virus (HBV); Tumor necrosis factor--induced protein 3-interacting protein 1 (TNIP1); Association study; GENOME-WIDE ASSOCIATION; NF-KAPPA-B; VIRUS; BINDING; LOCI; COREPRESSOR; EXPRESSION; NUCLEAR; PROTEIN; GAMMA;
D O I
10.1007/s10528-018-9882-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic hepatitis B virus (HBV) infection is an important etiology for the development of hepatocellular carcinoma (HCC). Tumor necrosis factor--induced protein 3-interacting protein 1 (TNIP1) is linked to specific inflammatory diseases as a novel type of endogenous inflammatory regulator. However, presently, rare information is found about the association between TNIP1 polymorphisms and HBV-induced HCC risk. In this case control study, we genotyped four single nucleotide polymorphisms (SNPs) in TNIP1 gene in 248 HCC patients and 242 chronic HBV carriers using Sequenom Mass-ARRAY technology. Genetic model and haplotype analysis were performed to evaluate the association between candidate SNPs polymorphisms and HBV-induced HCC susceptibility using Pearson's (2) test and unconditional logistic regression analysis. Overall, we found two risk alleles in TNIP1 for HBV-induced HCC in patients: the allele G of rs7708392 by genotype model (G/C vs. C/C: OR 1.88, 95% CI 1.17-3, P=0.009) and dominant model (G/C-G/G vs. C/C: OR 1.69, 95% CI 1.08-2.65, P=0.023), and the allele C of rs10036748 by genotype model (C/T vs. T/T: OR 1.83, 95% CI 1.14-2.92, P=0.012) and dominant model (C/T-C/C vs. T/T: OR 1.65, 95% CI 1.05-2.59, P=0.03). However, rs3792792 and rs4958881 polymorphisms didn't significantly correlate with the risk of HBV-induced HCC. Haplotype analysis showed no significant association between haplotypes and the HCC risk in HBV carriers. This study provides evidence for HBV-induced HCC susceptibility gene TNIP1 in the Chinese Han population.
引用
收藏
页码:117 / 128
页数:12
相关论文
共 50 条
  • [41] A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis
    Mai, Haoming
    Xie, Haisheng
    Hou, Jia
    Chen, Haitao
    Zhou, Bin
    Hou, Jinlin
    Jiang, Deke
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 1055 - 1064
  • [42] SPP1 promoter polymorphisms and glioma risk in a Chinese Han population
    Juxiang Chen
    Qihan Wu
    Yicheng Lu
    Tao Xu
    Yan Huang
    Judit Ribas
    Xiaohua Ni
    Guohan Hu
    Fengping Huang
    Liangfu Zhou
    Daru Lu
    Journal of Human Genetics, 2010, 55 : 456 - 461
  • [43] Association between SNPs in miRNA-machinery genes and chronic hepatitis B in the Chinese Han population
    Shang, Mengqiao
    Huang, Yanchun
    Hu, Xuejiao
    Wang, Jun
    Song, Xingbo
    Zhou, Yi
    Zhou, Juan
    Ye, Yuanxin
    Lu, Xiaojun
    Tao, Chuanmin
    Wang, Lanlan
    Ying, Binwu
    INFECTION GENETICS AND EVOLUTION, 2014, 28 : 113 - 117
  • [44] Association between clusterin polymorphisms and esophageal squamous cell carcinoma risk in Han Chinese population
    Li, Kun
    Wang, Jian
    Ma, Zhen-Bin
    Guo, Guang-Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 14004 - 14010
  • [45] Prospective appraisal of clinical diagnostic algorithms for hepatocellular carcinoma surveillance in Chinese patients with chronic hepatitis B infection
    Chan, Henry L. Y.
    Hu, Yao
    Malinowsky, Katharina
    Madin, Kairat
    Kroeniger, Konstantin
    Hou, Jinlin
    Sharma, Ashish
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [46] Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B
    Zhang, Yuan-Qing
    Peng, Li-Jun
    Cao, Yi-Rong
    Zeng, Zhi-Ping
    Wu, Yu-Jing
    Shi, Hong
    Cheng, Shi-Yao
    Wang, Ji-Yao
    Friedman, Scott L.
    Sninsky, John J.
    Guo, Jin-Sheng
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (09) : 535 - 543
  • [47] Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
    Goh, Myung Ji
    Sinn, Dong Hyun
    Kim, Seonwoo
    Woo, Sook Young
    Cho, Hyun
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    HEPATOLOGY, 2020, 71 (06) : 2023 - 2032
  • [48] Association of interleukin-18 gene polymorphisms with the outcomes of hepatitis C virus infection in high-risk Chinese Han population
    Yue, Ming
    Wang, Jia-jia
    Tang, Shai-di
    Feng, Le
    Zhang, Yun
    Liu, Yan
    Wang, Jie
    Deng, Xiao-zhao
    Xu, Ke
    Zhang, Jun
    IMMUNOLOGY LETTERS, 2013, 154 (1-2) : 54 - 60
  • [49] Association of ACYP2 and MPHOSPH6 genetic polymorphisms with the risk of hepatocellular carcinoma in chronic hepatitis B virus carriers
    Zhang, Yingai
    Wang, Shunlan
    Wen, Xiaohong
    Zhang, Shufang
    Yang, Yijun
    ONCOTARGET, 2017, 8 (49) : 86011 - 86019
  • [50] Interleukin-17A and interleukin-17F gene polymorphisms and hepatitis B virus-related hepatocellular carcinoma risk in a Chinese population
    Xi, Xue-E
    Liu, Yanqiong
    Lu, Yu
    Huang, Liying
    Qin, Xue
    Li, Shan
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 8